ABN AMRO Investment Solutions’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Buy
44,651
+31,915
+251% +$6.63M 0.09% 150
2026
Q1
$2.69M Buy
12,736
+1,504
+13% +$324K 0.04% 293
2025
Q4
$2.31M Buy
11,232
+7,259
+183% +$1.37M 0.03% 305
2025
Q3
$624K Sell
3,973
-414
-9% -$64K 0.01% 326
2025
Q2
$737K Buy
4,387
+864
+25% +$128K 0.01% 321
2025
Q1
$485K Buy
3,523
+524
+17% +$66.8K 0.01% 334
2024
Q4
$355K Buy
2,999
+219
+8% +$25.6K 0.01% 392
2024
Q3
$307K Sell
2,780
-359
-11% -$37.5K 0.01% 437
2024
Q2
$309K Buy
+3,139
New +$320K 0.01% 428

Other funds holding CAH

ABN AMRO Investment Solutions's CAH Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its Cardinal Health (CAH) stake by 251% in Q2 2026, buying an estimated $6.63M and bringing the position to 44,651 shares worth $10.6M. The position accounts for 0.09% of the portfolio, ranked #150.

ABN AMRO Investment Solutions first reported a position in CAH in Q2 2024 and has held it in 9 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • ABN AMRO Investment Solutions held 44,651 shares of Cardinal Health worth $10.6M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 31,915 Cardinal Health shares in Q2 2026, an estimated $6.63M.
  • Cardinal Health made up 0.09% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #150 holding.
  • ABN AMRO Investment Solutions first reported a position in Cardinal Health in Q2 2024 and has held it in 9 quarters since.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.